{
  "name" : "dacemirror.sci-hub.se_journal-article_465d3d1910f6ccf06ac19591c077e79d_dukenbayev2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Fe3O4 Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy",
    "authors" : [ "Kanat Dukenbayev", "Ilya V. Korolkov", "Daria I. Tishkevich", "Artem L. Kozlovskiy", "Sergey V. Trukhanov", "Yevgeniy G. Gorin", "Elena E. Shumskaya", "Egor Y. Kaniukov", "Denis A. Vinnik", "Maxim V. Zdorovets", "Marina Anisovich", "Alex V. Trukhanov", "Daniele Tosi" ],
    "emails" : [ "kdukenbayev@nu.edu.kz", "daniele.tosi@nu.edu.kz", "carlo.molardi@nu.edu.kz", "korolkovelf@mail.ru", "kozlovskiy.a@inp.kz", "gorineg@mail.ru", "mzdorovets@gmail.com", "sv_truhanov@mail.ru", "shumska.alena@gmail.com", "ka.egor@mail.ru", "truhanov86@mail.ru", "vinnikda@susu.ru", "m_anisovich@mail.ru", "dashachushkova@gmail.com" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Keywords: magnetic nanoparticles; iron oxide; surface functionalization; APTMS; carborane\nNanomaterials 2019, 9, 494; doi:10.3390/nano9040494 www.mdpi.com/journal/nanomaterials\nNanomaterials 2019, 9, 494 2 of 19"
    }, {
      "heading" : "1. Introduction",
      "text" : "Magnetic iron oxide nanoparticles (NPs), such as magnetite (Fe3O4) and maghemite (γ-Fe2O3), have been found and applied in a wide range of biomedical applications [1–9], including magnetic resonance imaging, magnetic hyperthermia, cancer therapy, and drug delivery; they also find applications in catalysis [10–12] and in magnetic separation [13,14]. Among other metal nanoparticles, iron oxide nanoparticles have been more extensively studied in clinical practice [15]. A wide range of Fe3O4 NPs’ applications are derived from unique properties, such as the superparamagnetism, high surface area, and nanometer-level size [8]. At the same time, iron oxide NPs, stand-alone, have a tendency for agglomeration, low stability in solutions, and insufficient biocompatibility. The application of iron oxide NPs in medicine reveals one more issue: An intravenous delivery agent should be eliminated from the blood and not cause accumulation in the organism, which can lead to side effects. Arami et al. [16] showed that iron oxide NPs are safe and non-toxic with a median lethal dose of 300–600 mgFe/kg. Zang et al. [17] reported that the accumulation and elimination of iron oxide NPs were found on a sample of zebrafish, and as a result, magnetic nanoparticles were eliminated from 86% to 100% by 24 days. Weissleder et al. [18] studied the toxic effect on rats and beagle dogs, revealing that no toxicity was detected in animals that received 3000 mmol Fe/kg overall. Furthermore, various materials, such as silane-based compounds, metals, polymers, and fatty and amino acids, have been used for coating and stabilizing the surface of iron oxide NPs in order to reduce toxicity and increase biocompatibility [19–21]. Among other materials, silane-based compounds are most promising since they have high biocompatibility, stability, low toxicity, low cost, and high prospects for functionality [22–25]. Also, the modification of iron oxide NPs by silanes with functional groups can lead to an easy attachment of payloads. One of these payloads can be a boron-rich compound for potential use as drug in boron neutron capture therapy of cancer (BNCT). BNCT is a promising method of cancer treatment based on selective accumulation of boron-rich compounds inside the cancer cells and its neutron irradiation. Boron compounds and neutrons collide and cause atomic fission, producing α-Ray radiation; as a result, cancer cells are damaged from the inside [26]. BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31]. However, BNCT has limitations, which are the high concentration of thermal neutrons in the order of 10 n/cm2 and high concentration of boron-10 in the tumor (20–35 µg per 1 g of tissue) [32,33]. These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41]. The main requirements for the use of nanostructures as containers for targeted drug delivery are the possibility of transporting drugs directly to the affected tissues or organs, reducing side effects, and the non-toxicity and stability of the carriers [26]. Among them, magnetic iron oxide NPs are preferable due to the potential possibility of drug targeting into each specific site of the disease [42]. Zhu et al. [40] studied the effective method of carborane (10 atoms per molecule) immobilization on Fe3O4 NPs by catalytic azide-alkyne cycloaddition reactions. However, this method is complicated (consisting of three stages) and required expensive reagents. Moreover, it is necessary to increase the concentration of boron content for successful application in BNCT. In this paper, we present the result of Fe3O4 NPs modification with (3-aminopropyl)-trimethoxysilane (APTMS) and subsequent simple attachment with carborane borate, containing 21 boron atoms. The stability of this system was elucidated by using a model-solution with simulated body fluid (pH = 7.4). The biocompatibility was evaluated in vitro using cultured mouse embryonic fibroblasts."
    }, {
      "heading" : "2. Materials and Methods",
      "text" : "The structural and magnetic properties of magnetic NPs and the dynamics of their degradation in phosphate buffer were studied, as well as the method of modifying particles with an organosilicon compound, in order to prevent degradation of the NPs’ surface. The possibility of immobilizing\nNanomaterials 2019, 9, 494 3 of 19\ncarboranes on a functionalized surface was studied. Structural changes and their effects on the magnetite properties of the resulting composite particles were determined. To identify the toxicity of the magnetic particles themselves, composites, and the attached carboranes, toxicological studies were carried out on an MTT (methyltetrazolium test) assay with different NPs using mouse embryonic fibroblasts (MEFs). The scheme of the proposed research is presented in Figure 1.\nNanomaterials 2019, 9, x FOR PEER REVIEW  3  of  19 \nimmobilizing  carboranes  on  a  functionalized  surface was  studied.  Structural  changes  and  their  effects on the magnetite properties of the resulting composite particles were determined. To identify  the  toxicity  of  the  magnetic  particles  themselves,  composites,  and  the  attached  carboranes,  toxicological studies were carried out on an MTT (methyltetrazolium test) assay with different NPs  using mouse embryonic  fibroblasts  (MEFs). The  scheme of  the proposed  research  is presented  in  Figure 1. \nFigure 1. Schematic representation of the study. \n2.1. Synthesis and Modification of Fe3O4 NPs \nNPs based on iron oxide were obtained by co‐precipitation of a mixture of iron (II) chloride and  (III) chloride with the addition of ammonium hydroxide. This reaction can be represented as follows: \nFeCl2 + 2FeCl3 + 8NH3 · H2O→Fe3O4 + 8NH4Cl + 4H2O.   \n2 M FeCl2 was dissolved in 2 M HCl, 1 M FeCl3 in a molar ratio of 1:2. 50 mL of NH4OH (0.7 M)  was added dropwise through the funnel to the resulting solution over a period of 5–10 min, while  stirring with  a magnetic  stirrer.  After  the  synthesis,  the  resulting  samples were washed  in  an  ultrasonic bath and dried at 50 °C for 24 h. \n2.2. Amine Functionalization of NPs and Carborane Immobilization \nAmine  functionalization  of  the NPs’  surface was done  by  adding  1 mL  of  (3‐aminopropyl)  trimethoxysilane  (APTMS) with a  concentration of 20 mM  in  ethanol  to Fe3O4 NPs. The  reaction  mixture was ultrasonicated for 30 min and kept in these solutions for 24 h.  After amine functionalization, the samples were dried and washed in ethanol. For the binding,  carborane with  an  aminated  surface  of  the  powder  of  the NPs was  added  to  0.1 M  solution  of  carborane borate, synthesized as in [43]    in ethanol, and the reaction mixture was ultrasonicated for  30 min and was kept in a shaker for 24 h. After completing the reaction, the samples were washed  with ethanol and dried. \n2.3. Methods of Characterization "
    }, {
      "heading" : "2.1. Synthesis and Modification of Fe3O4 NPs",
      "text" : "NPs based on iron oxide were obtained by co-precipitation of a mixture of iron (II) chloride and (III) chloride with the addition of ammonium hydroxide. This reaction can be represented as follows:\nFeCl2 + 2FeCl3 + 8NH3 · H2O→Fe3O4 + 8NH4Cl + 4H2O.\n2 M FeCl2 was dissolved in 2 M HCl, 1 M FeCl3 in a molar ratio of 1:2. 50 mL of NH4OH (0.7 M) was added dropwise through the funnel to the resulting solution over a period of 5–10 min, while stirring with a agnetic stirrer. After the synthesis, the resulting samples were ashed in an ultrasonic bath and dried at 50 ◦C for 24 h."
    }, {
      "heading" : "2.2. Amine Functionalizati n of NPs and Carborane Immobilization",
      "text" : "Amine functionalization of the NP ’ surface was done by adding 1 mL of (3-aminopropyl) trimethoxysilane (APTMS) with a concen ration of 20 mM in ethanol to Fe3O4 NPs. Th reaction mixture was ultrasonicated for 30 min and kept in th e solutions for 24 h. After amine functionalization, the samples were dried and washed in ethanol. For the binding, carborane with an aminated of the powder of the NPs was added to 0.1 M solution of carborane\nrate, synth sized as in [43] in ethanol, and the reaction mixture was ultrasonica ed for 30 min and was kept in a shaker for 24 h. After completing the r action, th samples were washed with ethanol and dried.\nNanomaterials 2019, 9, 494 4 of 19"
    }, {
      "heading" : "2.3. Methods of Characterization",
      "text" : "Structural and compositional analysis was performed with either a JEOL JEM 2100 LaB6 (JEOL Ltd, Akishima, Tokyo, Japan), or with a ARM200F transmission electron microscope TEM, JEOL Ltd, Akishima, Tokyo, Japan) operated at 200 kV. X-ray diffraction analysis was carried out on a D8 ADVANCE ECO diffractometer (Karlsruhe, Germany) using CuKα radiation. In order to identify the phases and study the crystal structure, the software, BrukerAXSDIFFRAC.EVAv.4.2 (Bruker, Karlsruhe, Germany), and the international ICDD PDF-2 database were used. FTIR (Fourier transform infrared spectroscopy) spectra were recorded on an Agilent Technologies Cary 600 Series FTIR Spectrometer with Single Reflection Diamond Attenuated total reflectance (ATR) accessory (GladiATR, PIKE, Fitchburg, WI, USA) to study chemical group shifts before and after NPs’ modification. Measurements were taken in the range of 400 to 4000 cm−1. All spectra (40 scans at a 4.0 cm−1 resolution) were recorded at 21–25 ◦C. Spectral analysis was conducted by using Agilent Resolution Pro. The Mössbauer studies were carried out using a spectrometer, MS1104Em (Chernogolovka, Russia). The 57Co nuclei in the Rh matrix were used as a source. The Mössbauer spectrometer was calibrated at room temperature with a α-Fe standard. The investigation of the magnetic properties was carried out using the vibrational magnetometer system (VSM, Liquid Helium Free High Field Measurement System “Cryogenic Ltd.”, London, UK). The measurements were implemented by the induction method, through a determination of the induced electromotive force of the induction in signal coils by a magnetized sample oscillating with a definite frequency at magnetic field of H = ±20,000 Oe at a 300 K temperature."
    }, {
      "heading" : "2.4. Stability of Fe3O4 NPs",
      "text" : "PBS solution was prepared from PBS tablets (Sigma-Aldrich, St.Louis, MO, USA) to obtain a 137 mM NaCl, 2.7 mM KCl, and 10 mM phosphate buffer solution (pH 7.4 at 25 ◦C). Samples were immersed into PBS solution for 1, 5, and 10 days, and the sample was then washed with deionized water, dried, and weighted. Control was performed by using XRD, Mössbauer spectroscopy, and DLS analysis (Malvern Panalytical, Malvern, UK)."
    }, {
      "heading" : "2.5. Cytotoxicity",
      "text" : "The biocompatibility of Fe3O4 NPs, Fe3O4-Aminated NPs and Fe3O4-Carborane NPs was studied in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT assay with different NPs concentration from 0.005 to 0.6 mg/mL using mouse embryonic fibroblasts (MEFs). All tests were carried out at temperature of 20–22 ◦C, humidity of 32–44%, and atmospheric pressure of 733–745 mmHg using a centrifuge OPN-3, microscope Axiovert 40C and 40, thermohygrometer Testo-608-H-1 (Testo, Moscow, Russia).\n2.5.1. Preparation of Cells\nThe material for the MEFs culture was obtained by disaggregating the skin and muscle tissue of 12–14-day mouse embryos using 0.25% trypsin solution at 37 ◦C for 30 min [44]. After the removal of trypsin, the sediment was suspended in growth medium (90% of Dulbecco’s Modified Eagle Medium (DMEM), 10% of fetal calf serum with the addition of antibiotics). The suspension was passed through a filter (cell 0.3 × 0.3 mm). After counting in the Goryaev chamber, cells were sown in vials with a seed density of 100–300 thousand per 1 cm2 of growth surface and cultured in a growth medium for 5–7 days. The number of cells of different morphotypes was counted in accordance with the classification of Bayreuter [45].\nNanomaterials 2019, 9, 494 5 of 19\n2.5.2. Cell Cytotoxicity Assay (MTT)\nThe MTT is an assay to identify metabolic disorders, namely, the dysfunction of mitochondria, reflecting the effect on cell viability. Cells were grown in a CO2 incubator (Herra Cell) at 37 ◦C, 5% CO2, 80% relative humidity on 96-well plates (seed concentration—50–70 thousand cells/mL). Samples of NPs dissolved in fetal bovine serum (Sigma, St.Louis, MO, USA) were added to the wells with adherent cells (second day of cultivation). After a 24-h exposure of the samples, total cell mitochondrial dehydrogenase activity in each well was measured photometrically in the methyltetrazolium test (MTT). This test is based on the ability of living metabolically active cells to convert the tetrazoline salt (MTS) into formazan, which is soluble in the culture medium. Thus, the absorption of formazan is directly proportional to the number of viable cells in the culture. CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS), Promega kit, was used for MTT. To measure the absorption of formazan, the cells were incubated with MTS for 4 h in a thermostat, and the measurement of the absorption of formazan at λ = 490 nm was performed on an automatic microplate photometer EIX808, BioTek Instruments Inc., Winooski, VT, USA. The toxicity of nanoparticles was assessed by IC50."
    }, {
      "heading" : "3. Results",
      "text" : ""
    }, {
      "heading" : "3.1. Synthesis of Fe3O4 Nanoparticles",
      "text" : "Fe3O4 NPs were synthesized using a mixture of iron (II) and (III) chloride with the addition of ammonium hydroxide [46]. As a result, spherical NPs with sizes up to 20 nm, according to the TEM images (Figure 2a), were produced. The same sizes varied from 8.64 to 28 nm and the average size of 18.9 nm was verified by DLS analysis (Figure 2b).\nNanomaterials 2019, 9, x FOR PEER REVIEW  5  of  19 \nCO2,  80%  relative  humidity  on  96‐well  plates  (seed  concentration—50–70  thousand  cells/mL).  Samples of NPs dissolved in fetal bovine serum (Sigma, St.Louis, MO, USA) were added to the wells  with  adherent  cells  (second  day  of  cultivation). After  a  24‐h  exposure  of  the  samples,  total  cell  mitochondrial  dehydrogenase  activity  in  each  well  was  measured  photometrically  in  the  methyltetrazolium test (MTT). This test is based on the ability of living metabolically active cells to  convert the tetrazoline salt (MTS) into formazan, which is soluble in the culture medium. Thus, the  absorption of formazan is directly proportional to the number of viable cells in the culture. CellTiter  96® AQueous One  Solution Cell Proliferation Assay  (MTS), Promega kit, was used  for MTT. To  measure the absorption of formazan, the cells were incubated with MTS for 4 h in a thermostat, and  the measurement  of  the  absorption  of  formazan  at  λ  =  490 nm was performed  on  an  automatic  microplate  photometer  EIX808,  BioTek  Instruments  Inc.,  Winooski,  VT,  USA.  The  toxicity  of  nanoparticles was assessed by IC50. \n3. Results \n3.1. Synthesis of Fe3O4 Nanoparticles \nFe3O4 NPs were synthesized using a mixture of iron (II) and (III) chloride with the addition of  ammonium hyd oxide [46]. As a result, spherical NPs with sizes up to 20 nm, according to the TEM  images (Figu e 2a), were produced. The same size  varied from 8.64 to 28 nm and the average size of  18.9 nm was verifi d by DLS analysis (Figure 2b). \n \nFigure 2. Characteristics of the initial magnetic nanoparticals: (a) TEM image; (b) size distribution, (c) \nXRD diffractogram; (d) Mössbauer spectra and the distribution of the hyperfine magnetic field; (е) \nhysteresis loop. \nAccording  to  X‐ray  diffraction  analysis  (Figure  2c),  the  synthesized  nanoparticles  are  polycrystalline of magnetite Fe3O4 with a cubic structure; the lattice parameter, a = 8.24467 ± 0.00013  Å, differs from the reference value (PDF—01‐075‐9673, Fe3O4—Cubic, Fd‐3m(227) a = 8.34800 Å). The \nFigure 2. Characteristics of the initial magnetic nanoparticals: (a) TEM image; (b) size distrib ti , (c) diffract r ; ( ) fi fi (e) hysteresis loop.\nNanomaterials 2019, 9, 494 6 of 19\nAccording to X-ray diffraction analysis (Figure 2c), the synthesized nanoparticles are polycrystalline of magnetite Fe3O4 with a cubic structure; the lattice parameter, a = 8.24467± 0.00013 Å, differs from the reference value (PDF—01-075-9673, Fe3O4—Cubic, Fd-3m(227) a = 8.34800 Å). The results of the X-ray phase analysis on the formation of magnetite nanoparticles are confirmed by the results of the Mössbauer spectroscopy. Unlike the X-ray diffraction patterns of nanoparticles, which are characterized by low-intensity broadened diffraction peaks that can correspond to both magnetite and maghemite due to the similarity of the crystal structure and main diffraction maxima, the analysis of the Mössbauer spectra makes it possible to accurately determine the magnitude of the hyperfine magnetic field, which is different for different iron oxide phases. The Mössbauer spectra of all the synthesized samples (Figure 2d) were taken at room temperature in the range of −10/+10 mm/s. The spectra correspond to a Zeeman sextet with broadened resonance lines, characteristic of Fe3O4. The Mössbauer data were analyzed using the method of restoration of the hyperfine parameters’ distributions of the Mössbauer spectrum taking into account a priori information about the samples. A model consisting of two sextets characteristic of tetrahedral (A-phase) and octohedral (B-phase) positions of iron atoms in the structure and a quadrupole doublet was used as a model for the analysis. According to literature data for nanoscale magnetite, the presence of two sextets is due to Fe3+ in the positions of the A sublattice (spinel) and intermediate valence states of Fe2.5+ in the positions of the B sublattice. According to the obtained data, the asymmetric shape and the broadening of the spectral lines is due to the presence of regions of disorder in the structure. The magnitudes of the hyperfine magnetic fields for the A and B sublattices are 472.5 ± 2.5 kOe and 442 ± 4.1 kOe, respectively, which is in good agreement with the literature data on the magnitudes of the hyperfine fields for magnetite nanostructures [47,48]. The ratio of the contributions of the partial spectra for the studied nanoparticles was Fe3+tetra/Fe3+,2+oct ≈ 0.57, which is close enough to the reference value of −0.5 characteristic of stoichiometric magnetite [49–51]. The deviation of the obtained ratio of contributions from the reference value is due to the presence in the structure of vacancy defects and regions of disorder that arise during the synthesis. The presence of a low-intensity quadrupole doublet in the structure, which is characteristic of cationic defects in the structure, indicates the presence of regions of disorder or impurity paramagnetic inclusions in the crystal structure, the presence of which is due to synthesis processes. The appearance of the hysteresis loop for the synthesized nanoparticles is characteristic of nanoscale soft ferromagnetic materials. The hysteresis loop (inserts to Figure 2e has a form typical for a superparamagnetic material. Increased fragments of loops (in the range of B = ±1000 Oe) demonstrate the magnetic characteristics: Coercivity is about 10 Oe, saturation magnetization is 68 emu/g, which is typical for Fe3O4 magnetic NPs [52]. The appearance of the hysteresis loop for the synthesized nanoparticles is characteristic of nanoscale soft ferromagnetic materials. The hysteresis loop (insets of Figure 2e has the typical form of a superparamagnetic material. The increased fragments of loops (in the range of B = ±1000 Oe) demonstrate the magnetic characteristics: Coercivity is about 10 Oe, saturation magnetization is 68 emu/g, which is typical for Fe3O4 magnetic NPs [52,53]."
    }, {
      "heading" : "3.2. Modification of Fe3O4 Nanoparticles",
      "text" : "Amine functionalization of the NPs’ surface was provided with organosilicon compound in order to prevent degradation and to functionalize the surface of NPs. A schematic representation of the functionalization and characteristics of the modified NPs is presented in Figure 3a. The formation of the bonds of the modifying agent with the surface of the NPs was proven by ATR-FTIR spectroscopy (Figure 3b). The ATR-FTIR spectrum of the initial Fe3O4 NPs is characterized by absorption at 3500–3000 cm−1 (OH groups), at 1614 cm−1 related to O–H bending vibrations combined with Fe atoms, and at 544 and 399 cm−1 corresponding to Fe–O. Aminated Fe3O4 NPs\nNanomaterials 2019, 9, 494 7 of 19\nare characterized by new peaks at 1602 cm−1 (NH2), at 1223 and 994 cm−1 (Si–C), and at 1050 and 1112 cm−1 (Si–O–Si). X-ray diffraction patterns of the modified samples (Figure 3c) in the range of 2θ = 15–25◦ show the presence of peaks corresponding to APTMS (hexagonal type). An increase in the lattice parameter of a = 8.30458 Å for the modified samples indicates the interaction of these compounds (APTMS) with the crystalline structure of NPs by replacing iron or oxygen atoms in the lattice sites or introducing them into interstitial sites [54]. Particle size distribution after amination is presented in Figure 3d. There is a slight increase in the average size compared with the initial Fe3O4 NPs EDX (energy-dispersive X-ray, Hitachi, Chiyoda, Tokyo, Japan) analysis was performed in order to obtain the element ratio variations after modification with APTMS and are presented in Table 1. It was found that amination with APTMS led to the appearance of Si and N in the atomic content of NPs. Nanomaterials 2019, 9, x FOR PEER REVIEW  7  of  19 \nFigure 3. Characteristics of the functionalized magnetic nanoparticles: (a) Schematic representation \nof the modification of magnetic nanoparticals by organosilicon compound (APTMS); (b) FTIR spectra, \n(c) XRD diffractogram; (d) size distribution; (e) Mössbauer spectra; (f) distribution of the hyperfine \nmagnetic field; (g) hysteresis loop. \nThe formation of the bonds of the modifying agent with the surface of the NPs was proven by \nATR‐FTIR spectroscopy (Figure 3b). The ATR‐FTIR spectrum of the initial Fe3O4 NPs is characterized  by  absorption  at  3500–3000  cm−1  (OH  groups),  at  1614  cm−1  related  to O–H  bending  vibrations  combined with Fe atoms, and at 544 and 399 cm−1 corresponding to Fe–O. Aminated Fe3O4 NPs are  characterized by new peaks at 1602 cm−1 (NH2), at 1223 and 994 cm−1 (Si–C), and at 1050 and 1112  cm−1 (Si–O–Si).  X‐ray diffraction patterns of the modified samples (Figure 3c) in the range of 2θ = 15–25° show  the  presence  of  peaks  corresponding  to  APTMS  (hexagonal  type).  An  increase  in  the  lattice  parameter of a = 8.30458 Å for the modified samples indicates the interaction of these compounds  (APTMS) with the crystalline structure of NPs by replacing iron or oxygen atoms in the lattice sites  or introducing them into interstitial sites [54]. Particle size distribution after amination is presented  in Figure 3d. There is a slight increase in the average size compared with the initial Fe3O4 NPs    EDX  (energy‐dispersive  X‐ray, Hitachi,  Chiyoda,  Tokyo,  Japan)  analysis was  performed  in  order  to obtain  the element  ratio variations after modification with APTMS and are presented  in  Table 1. It was found that amination with APTMS led to the appearance of Si and N in the atomic  content of NPs. \nTable  1.  Element  ratio  variations  by using  the EDX method  of magnetic nanoparticles  and  after  modification with APTMS. \nSample  Atomic Content, % \n[NH2], μM/g  N  Fe  Si  O \nFe3O4 NPs  ‐  43.1  ‐  56.9  ‐ \nFe3O4‐Aminated NPs  1. 0 \n36.0  2. 3 \n60.7  86.57 \nTable 1. Element ratio variations by using the EDX method of magnetic nanoparticles and after modification with APTMS.\nSample Atomic Content, %\n[NH2], µM/g N Fe Si O\nFe3O4 NPs - 43.1 - 56.9 -\nFe3O4-Aminated NPs 1.0 36.0 2.3 60.7 86.57\nAs for the initial NPs, the spectra of the modified ones (Figure 3e) correspond to a Zeeman sextet with broadened resonance lines, characteristic of Fe3O4, and a quadrupole doublet, characteristic of the paramagnetic state of Fe2+ and Fe3+. The decrease in the hyperfine field (Figure 3f) for the modified\nNanomaterials 2019, 9, 494 8 of 19\nsamples by APTMS to 466.8 ± 2.1 kOe and 432 ± 1.7 kOe is due to the modification of the NPs’ surface, the change in the structural bonds, and the introduction of –Si, –O, and –NH3 into the interstice of the crystal lattice, thus leading to its change [49,55,56]. Increased fragments (inserts to Figure 3g) of loops (in the range of B = ±1000 Oe) demonstrate a slight decrease in the magnetic characteristics in comparison with the initial Fe3O4 NPs, caused by changing the present nonmagnetic faze on the magnetic NPs’ surface: Coercivity is about 6 Oe, saturation magnetization is 62 emu/g, and this is close to the magnetic parameters of Fe3O4 NPs, as indicated in [57]. Thus, the proposed method for the functionalization of magnetic nanoparticles allows the surface of nanostructured samples to be aminated, which was confirmed with the results of the FTIR, XRD, and EDX analysis and Mössbauer spectroscopy. The slight changes in structure lead to an insignificant increase in particle size, and the appearance of non-magnetic inclusions that make a slight contribution to the magnetic characteristics of the resulting composite material. Due to the presence of amino groups on the surface of the samples, it becomes possible to attach payloads to the surface of magnetic nanoparticles, which is a promising lead to be used as magnetic nanoscale carriers for targeted drug delivery, bioseparation, and other biological applications. The obtained results are in good agreement with previous work on the functionalization of the surface of oxide nanoparticles and their potential use in biomedicine and targeted drug delivery [55,58,59]. Magnetic media used for biological purposes should have the following properties: Maintain their structural, chemical, and physical properties over time, while being in biological environments; not have a direct toxicological effect on biological objects (cells); the procedure for the addition of drugs to magnetic NPs should be simple and should not affect the particles themselves and the attached substances. In order to confirm the possibility of using the obtained magnetic NSs in bio-medical applications, the following studies were conducted:\n1 Dynamics of changes in structural properties over a model environment, similar in properties to biological fluids (PBS solution with an acidity of 7.4 t = 25 ◦ C).\n2 Immobilization of carboranes on the functionalized amino groups’ surface of the nanoparticles. 3 Study of the toxicological properties of the magnetic carrier, magnetic carrier with a functionalized\nsurface, and samples with immobilized carboranes."
    }, {
      "heading" : "3.3. Stability of Fe3O4 NPs in PBS Solution",
      "text" : "One of the important parameters of the use of NPs as magnetic carriers for targeted drug delivery is their resistance to degradation in various media. PBS solution with an acidity of 7.4 is widely used as simulated body fluid for degradation testing of magnetic carriers [60–62]. The most common mechanism of degradation is amorphization and the subsequent destruction of the crystal structure and the deterioration of the magnetic characteristics of NPs. It is necessary to know the exact time of the change in the properties of NPs in order to determine the optimal area and time of effective application. Figure 4 shows the changes in the main diffraction peaks of the initial and modified Fe3O4 NPs, depending on the time of degradation. The time range of measurements was 10 days, control points: 1, 5, and 10 days.\nNanomaterials 2019, 9, 494 9 of 19a o aterials 2019, 9, x FOR PEER REVIEW  9     \nFigure 4. The changes in the main diffraction peaks of (a) the initial and (b) modified Fe3O4 NPs. \nAccording to the presented data, no new diffraction peaks appear in the diffractograms of the  samples, which  indicates  the absence of phase  transformations  in the process of degradation. The  result of the calculations of the structural parameters (relative change of lattice parameter (a0 − a)/a0,  crystalline size, crystallinity) as well as in the size of NPs, studied by the DLS method, and changes  in  the  structure,  investigated  based  on  the  Mössbauer  spectra,  are  presented  in  Table  2.  By  approximating the lines of the diffractogram with the necessary number of symmetric pseudo‐Voigt  functions, the width of the recorded lines at half of their height (FWHM, full‐width half maximum)  was measured, which allowed us to characterize the perfection of the crystal structure and estimate  the degree of crystallinity [63,64]: \n\uD835\uDC43\uD835\uDC49 \uD835\uDC65, \uD835\uDC65 , \uD835\uDF02, \uD835\uDC4F , \uD835\uDC4F , \uD835\uDC34 \uD835\uDC34 1 \uD835\uDF02 \uD835\uDC3A \uD835\uDC65, \uD835\uDC65 , \uD835\uDC4F \uD835\uDF02 \uD835\uDC3F \uD835\uDC65, \uD835\uDC65 , \uD835\uDC4F , \n(1)  \uD835\uDC3A \uD835\uDC65, \uD835\uDC65 , \uD835\uDC4F exp \uD835\uDC65 \uD835\uDC652\uD835\uDC4F , \n\uD835\uDC3F \uD835\uDC65, \uD835\uDC65 , \uD835\uDC4F 11 \uD835\uDC65 \uD835\uDC65\uD835\uDC4F ^2  \nwhere:  x—variable  corresponding  to  the  angle  of  reflection,  2θ;  x0—sets  the  position  of  the  maximum function; η—specific proportion of the Lorentz function; A—normalization factor; bG and  bL—Gauss  function  parameters,  G(x,  x0,  bG)  and  Lorentz  L(x,  x0,  bL).  As  a  criterion  for  such  compliance,  we  can  use  the  standard  deviation,  the  minimum  value  of  which,  when  these  parameters vary, corresponds to their optimal set: \n\uD835\uDF0E ∑ \uD835\uDC43\uD835\uDC49 \uD835\uDC65, \uD835\uDC65 , \uD835\uDF02, \uD835\uDC4F , \uD835\uDC4F , \uD835\uDC34 \uD835\uDC3C\uD835\uDC5B   (1) \nwhere:  \uD835\uDC43\uD835\uDC49 \uD835\uDC65, \uD835\uDC65 , \uD835\uDF02, \uD835\uDC4F , \uD835\uDC4F , \uD835\uDC34 —pseudo‐Voigt  function  value;  Ii—value  of  experimental  intensity;  i—reflex profile point number; n—number of points in the profile. Figure 5 shows the changes in the  Mössbauer spectra of the initial Fe3O4 NPs and aminated Fe3O4 NPs during degradation. \nAccording to the presented data, no new diffraction peaks appear in the diffractograms of the samples, which indicates the absence of phase transformations in the process of degradation. The result of the calculations of the structural parameters (relative change of lattice parameter (a0 − a)/a0, crystalline size, crystallinity) as well as in the size of NPs, studied by the DLS method, and changes in the structure, investigated based on the Mössbauer spectra, are presented in Table 2. By approximating the lines of the diffractogram with the necessary number of symmetric pseudo-Voigt functions, the width of the recorded lines at half of their height (FWHM, full-width half maximum) was measured, which allowed us to characterize the perfection of the crystal structure and estimate the degree of crystallinity [63,64]:\nPV(x, x0, η, bL, bG, A) = A[(1− η)·G(x, x0, bG) + η·L(x, x0, bL)], G(x, x0, bG) = exp [ − (x−x0) 2\n2b2G\n] ,\nL(x, x0, bL) = 1 1+ (\nx−x0 bL\n)2 ( )\nhere: x—variable corresponding to the angle of reflection, 2θ; x0—sets the position of the maximum function; η—specific proportion of the Lorentz function; A—normalization factor; bG and bL—Gauss function parameters, G(x, x0, bG) and Lorentz L(x, x0, bL). As a criterion for such compliance, we can use the standard deviation, the minimum value of which, when these parameters vary, corresponds to their optimal set:\nσ =\n√ ∑i (PV(x, x0, η, bL, bG, A)i − Ii) 2\nn (2)\nwhere: (PV(x, x0, η, bL, bG, A)i—pseudo-Voigt function value; Ii—value of experimental intensity; i—reflex profile point number; n—number of points in the profile. Figure 5 shows the changes in the Mössbauer spectra of the initial Fe3O4 NPs and aminated Fe3O4 NPs during degradation.\nNanomaterials 2019, 9, 494 10 of 19\nNanomaterials 2019, 9, 494 11 of 19\nNanomaterials 2019, 9, x FOR PEER REVIEW  10  of  19 \nFigure 5. Mössbauer spectra of the studied nanoparticles. \nThe main changes are associated with the decrease in the intensity and shape of the diffraction peaks, as well as a small shift of the peaks that indicates a change in the parameters of the crystal lattice and the size of crystallites. The largest changes in the intensities are observed for the initial unmodified Fe3O4 NPs. Less degradation of modified nanoparticles is due to the presence of organosilicon compounds coating the NPs’ surface, which actively interacts with the PBS medium less and reduces the rate of degradation. According to the data, the largest increase in the lattice parameter is also observed for unmodified Fe3O4 NPs, which is caused by the processes of the introduction of oxygen ions into the internode of the crystal lattice and its subsequent swelling [65,66]. Herewith, the modification of the surface leads to a smaller value of the parameter change, which, as mentioned above, is due to the low penetration of oxygen and hydrogen ions through the modified layer. An increase in the average crystallite size is observed for modified nanoparticles, which is caused by the modification of the crystal structure. The crystallite size was estimated using the Debye-Scherer method [67]. Degradation for 1 day led to a sharp increase in the average crystallite size of initial Fe3O4 NPs, which may be due to the incorporation of oxygen into the nanoparticle structure, in which changing the main crystallographic characteristics leads to a decrease in the degree of perfection of the crystal structure due to the formation of amorphous inclusions [68,69]. Fe3O4 modified with organosilicon compound shows smaller changes in the average crystallite size. A change in the crystal structure as a result of a decrease in the degree of perfection and the formation of amorphous inclusions can lead to magnetic disordering and a subsequent change in the magnitude of the hyperfine magnetic field. The results of a change in the magnitude of the hyperfine magnetic field, determined by Mössbauer spectroscopy, depending on the time of degradation, show that an increase in the degradation time leads to a change in the structural characteristics and the formation of amorphous inclusions in the structure, which in turn leads to a decrease in the magnitude of the hyperfine magnetic field [70,71]. This is due to the formation of cationic vacancies and impurity inclusions in the structure, as well as the disordering of the magnetic texture [72].\nNanomaterials 2019, 9, 494 12 of 19\nThus, modified Fe3O4 NPs with APTMS showed great stability in PBS solution during 1–10 days. XRD analysis and Mössbauer spectroscopy show minor changes in the crystal structure associated with an increase of the crystallites’ sizes and a decrease in the degree of perfection of the crystal parameters. At the same time, the products of degradation, such as FeOOH or Fe3(PO4)2, as they were previously reported in [61,62] were not detected. Excellent colloidal stability is associated with the stabilization of the system by electrostatic and steric repulsion. For the initial Fe3O4 NPs, the average hydrodynamic size of NPs increased from 18.9 to 27.9 nm, while for the Fe3O4-Aminated NPs, it increased from 22.4 to 26.2 nm, during 10 days when kept in PBS solution. The largest changes in hydrodynamic size occurred in the initial Fe3O4 NPs (9 nm), the smallest changes in the Fe3O4-Aminated NPs. The obtained data are in good agreement with the data on XRD analysis."
    }, {
      "heading" : "3.4. Immobilization of Carborane Borate",
      "text" : "Attachment of carborane was carried out through the ionic interaction of carborane borate with amino groups of the modified Fe3O4 NPs (Figure 6a).\nNanomaterials 2019, 9, x FOR PEER REVIEW  13  of  19 \nthe range of 2θ = 15–25° show the presence of peaks corresponding to APTMS (hexagonal type) and  carborane borate (inset of Figure 6d). This indicates the formation of stable chemical bonds between  the coatings and the structure of the nanoparticles.  The Mössbauer spectra (Figure 6e) correspond to a Zeeman sextet with broadened resonance  lines,  characteristic  of  Fe3O4,  and  an  extended  quadrupole  doublet,  characteristic  of  the  paramagnetic state of Fe2+ and Fe3+. The broadened inhomogeneous lines of the spectra, as well as the  presence of a quadrupole doublet in the spectrum, indicate an increase of magnetic disordering in  the  structure and  the absence of a  selected magnetic  texture. The decrease  in  the hyperfine  field  (Figure  6f)  for  the modified  samples  of  452.1  ±  1.7  and  427±  2.1  kOe  for  samples with  attached  carborane borate is due to the modification of the NPs’ surface [74,75].  The hysteresis loop (Figure 6g) for the samples of NPs + APTMS + Carboranes is still apparent ,  but corresponds to soft ferromagnetic materials. The magnetic characteristics are: Coercivity is about  70  Oe,  saturation  magnetization  is  31  emu/g.  The  change  in  the  size  and  structure  of  NPs  functionalized  by  carborane  and  the properties  of  the modified  surface  influenced  the magnetic  properties  of NPs.  These  changes  are  possibly  associated with  an  increase  in  the  dipole–dipole  interaction between the particl s, leading to rather large changes in the coercivity. An increase in the  amount of  the nonmagnetic phase  (carboranes and amorphous phase)  leads  to  a decrease  in  the  specific saturation magnetization, thus remaining at a sufficiently high value. \nFigure 6. Characteristics of the system magnetic nanoparticles + APTMS + Carboranes. (a) Schematic \nrepresentation of  carborane derivatives  immobilization;  (b) FTIR  spectra;  (c)  size distribution;  (d) \nXRD diffractogram;  (e) Mössbauer spectra;  (f)  the distribution of  the hyperfine magnetic  field;  (g) \nhysteresis loop. \nTable 3. Element ratio variations by using the EDX method of Fe3O4 nanoparticles with carborane. \nSample  Atomic Content, % \nB  N  Fe  Si  O  Fe3O4‐Carborane NPs  11.4  2.0  33.5  12.2  40.9 \nBased on the FTIR spectra (Figure 6b), the mechanism of attaching carborane can be observed. The reaction of the NH2 bond with carborane borate led to the observation of new peaks at 2625 cm−1 (B–H of carborane core) and the appearance of NH3+ group vibrations at 1521 cm−1. The presented results are in good correlation with previously published work [43,73]. Based on the EDX spectra, the presence of B is confirmed in the FTIR results (Table 3).\nNanomaterials 2019, 9, 494 13 of 19\nThe size of NPs with carborane, estimated with DLS (Figure 6c), is slightly increased to 24.3 nm from 19.4 nm (initial NPs). According to the X-ray diffraction analysis (Figure 6d), an increase in the lattice parameter of a = 8.30786 Å (APTMS + Carborane) for the modified samples indicates the interaction of these compounds with the crystalline structure of NPs by replacing iron or oxygen atoms in the lattice sites or introducing them into interstitial sites. X-ray diffraction patterns of the modified samples in the range of 2θ = 15–25◦ show the presence of peaks corresponding to APTMS (hexagonal type) and carborane borate (inset of Figure 6d). This indicates the formation of stable chemical bonds between the coatings and the structure of the nanoparticles. The Mössbauer spectra (Figure 6e) correspond to a Zeeman sextet with broadened resonance lines, characteristic of Fe3O4, and an extended quadrupole doublet, characteristic of the paramagnetic state of Fe2+ and Fe3+. The broadened inhomogeneous lines of the spectra, as well as the presence of a quadrupole doublet in the spectrum, indicate an increase of magnetic disordering in the structure and the absence of a selected magnetic texture. The decrease in the hyperfine field (Figure 6f) for the modified samples of 452.1 ± 1.7 and 427± 2.1 kOe for samples with attached carborane borate is due to the modification of the NPs’ surface [74,75]. The hysteresis loop (Figure 6g) for the samples of NPs + APTMS + Carboranes is still apparent, but corresponds to soft ferromagnetic materials. The magnetic characteristics are: Coercivity is about 70 Oe, saturation magnetization is 31 emu/g. The change in the size and structure of NPs functionalized by carborane and the properties of the modified surface influenced the magnetic properties of NPs. These changes are possibly associated with an increase in the dipole–dipole interaction between the particles, leading to rather large changes in the coercivity. An increase in the amount of the nonmagnetic phase (carboranes and amorphous phase) leads to a decrease in the specific saturation magnetization, thus remaining at a sufficiently high value. Thus, we have demonstrated the possibility of immobilizing carboranes on the surface of magnetic NPs functionalized by amino groups. Following the proposed technique, stable chemical bonds are formed, ensuring the presence of carborane on the surface. It is important to note that the proposed method induces some changes in the structure of NPs and their surfaces, leading to a significant change in the structural and magnetic parameters. These changes, however, do not lead to the loss of the target properties of magnetic carriers. These methods, as well as the method of magnetic NPs, could be proposed for targeted delivery of carboranes using a magnetic field to a tumor in boron capture therapy."
    }, {
      "heading" : "3.5. Cytotoxicity",
      "text" : "As preliminary in vitro studies, the biocompatibility of modified and non-modified Fe3O4 NPs was tested by an MTT assay using MEFs. Cells were incubated with NP concentrations from 0.005 mg/mL to 0.6 mg/mL for 24 h. Figure 7a shows that NPs did not present any toxicity for a concentration up to 0.015 mg/mL. IC50 was determined graphically from the curve presented in Figure 7b, and the results are presented in Table 4. The IC50 for the initial Fe3O4 NPs is 0.110 mg/mL, and for Fe3O4-aminated NPs it is 0.091 mg/mL and for Fe3O4-Carboranes NPs it is 0.405 mg/mL. Fe3O4 NPs’ toxicity depends on a variety of factors, including the dose, exposure time, colloidal and chemical properties of the surface, the NPs’ hydrodynamic diameter, and NPs’ protein interactions [8].\nNanomaterials 2019, 9, 494 14 of 19\nNanomaterials 2019, 9, x FOR PEER REVIEW  14  of  19  Thus,  we  have  demonstrated  the  possibility  of  immobilizing  carboranes  on  the  surface  of  magnetic NPs functionalized by amino groups. Following the proposed technique, stable chemical  bonds are formed, ensuring the presence of carborane on the surface. It is important to note that the  proposed  method  induces  some  changes  in  the  structure  of  NPs  and  their  surfaces,  leading  to  a  significant change in the structural and magnetic parameters. These changes, however, do not lead  to  the  loss of  the  target properties of magnetic carriers. These methods, as well as  the method of  magnetic  NPs,  could  be  proposed  for  targeted  delivery  of  carboranes  using a magnetic  field  to a  tumor in boron capture therapy.  3.3. Cytotoxicity \nAs preliminary in vitro studies, the biocompatibility of modified and non‐modified Fe3O4 NPs  was tested by an MTT assay using MEFs. Cells were incubated with NP concentrations from 0.005  mg/mL  to  0.6  mg/mL  for  24  h.  Figure  7a  shows  that  NPs  did  not  present  any  toxicity  for  a  concentration  up  to  0.015  mg/mL.  IC50  was  determined  graphically  from  the  curve  presented  in  Figure 7b, and the results are presented in Table 4. The IC50 for the initial Fe3O4 NPs is 0.110 mg/mL,  and  for  Fe3O4‐aminated  NPs  it  is  0.091  mg/mL  and  for  Fe3O4‐Carboranes  NPs  it  is  0.405  mg/mL.  Fe3O4 NPs’ toxicity depends on a variety of factors, including the dose, exposure time, colloidal and \nFigure 7. Cytotoxic effect of modified and non‐modified Fe3O4 NPs (a) on cultured mouse embryonic  fibroblasts and its nonlinear curve fitting (b). \nTable 4. Inhibitory concentration (IC50) for samples using MEFs. \nNo.  Sample  IC50, mg/mL  1  Fe3O4 NPs  0.110  2  Fe3O4‐Aminated NPs  0.091  3  Fe3O4‐Carboranes NPs  0.405 \nThe  increased  cytotoxicity of NPs  coated with APTMS  can be explained by  the  fact  that  the  surface of Fe3O4‐Aminated NPs  contains positively  charged NH2‐groups  that  can electrostatically  interact  with  negatively  charged  cell  membranes  [54,76].  Subsequent  binding  of  carborane  neutralizes the amino group, which leads to a decrease in the cytotoxicity of Fe3O4‐Carboranes NPs.  It  is  noteworthy  that  a dose  of  about  0.5 mg/mL  for  any  compound  is  the maximum dose  allowed for testing in vitro, above which the effects are not specific. As can be seen from the obtained  data,  the  half  inhibitory  concentration  for  Fe3O4‐Carboranes  NPs  approaches  this  value.  This  suggests  that  Fe3O4‐Carboranes NPs  have  the  lowest  cytotoxicity.  Their  cytotoxicity  is  possibly \nTable 4. Inhibitory concentration (IC ) for samples using MEFs.\nNo. IC50, / L\n1 Fe3 4 s 0.110 2 Fe3O4-A inat 0.091 3 Fe3O4-Carboranes Ps 0.405\nThe increased cytotoxicity of NPs coated with APTMS can be explained by the fact that the surface of Fe3O4-Aminated NPs contains positively charged NH2-groups that can electrostatically interact with negatively charged cell membranes [54,76]. Subsequent binding of carborane neutralizes the amino group, which leads to a decrease in the cytotoxicity of Fe3O4-Carboranes NPs. It is noteworthy that a dose of about 0.5 mg/mL for any compound is the maximum dose allowed for testing in vitro, above which the effects are not specific. As can be seen from the obtained data, the half inhibitory concentration for Fe3O4-Carboranes NPs approaches this value. This suggests that Fe3O4-Carboranes NPs have the lowest cytotoxicity. Their cytotoxicity is possibly associated with a purely mechanical effect of the high concentration, which prevents adhesion and, accordingly, cell growth in culture."
    }, {
      "heading" : "4. Conclusions",
      "text" : "Magnetic Fe3O4 NPs with an average size of 18.9 nm were synthesized and modified with APTMS. NPs were characterized using FTIR, TEM, XRD, DLS, Mössbauer spectroscopy, and VSM. The technique of successful functionalization of the NPs’ surface by organosilicon compound (APTMS), thanks to which the functional properties of the NPs do not change, but the possibility of the immobilization of payloads to functional amino groups of the modified surface, was confirmed. To demonstrate the possibility of using synthesized nanoparticles as magnetic carriers for the purpose of targeted delivery, studies of the degradation of initial nanoparticles and nanoparticles functionalized with APTMS were carried out, the possibility of immobilizing carborane borates (target substances used for boron capture therapy) on a functionalized surface was carried out, and toxicological studies of both magnetic carriers and their modifications were performed. It was shown that magnetic NPs are prone to a slight change in their structure even in magnetic neutral medium (PBS). However, the use of APTMS as a surface functionalizing agent also contributed to reducing degradation. Carborane borate with 21 boron atoms per molecule was successfully attached to the amino group of nanoparticles modified with APTMS for potential use in BNCT. Despite some changes in the\nNanomaterials 2019, 9, 494 15 of 19\nstructural and magnetic properties, when using the proposed technique for immobilizing carboranes, the functional properties of the NPs and the stable chemical bonds formed by the carboranes with the surface suggest its applicability. The NPs Fe3O4 biocompatibility test showed an increase in the IC50 from 0.110 mg/mL for NPs Fe3O4 to 0.4005 mg/mL for Fe3O4-carborane NPs. The data obtained confirm the biocompatibility and stability of the synthesized Fe3O4-carborane NPs and identify the possibility of further testing as carriers for the targeted delivery of boron to cancer cells.\nAuthor Contributions: Conceptualization, K.D. and I.V.K.; methodology, D.I.T. and A.L.K.; validation, S.V.T. and A.V.T.; formal analysis, E.E.S.; investigation, M.A., E.Y.K. and Y.G.G.; resources, M.V.Z.; data curation, D.T.; writing—original draft preparation, review and editing, I.V.K., D.I.T., D.A.V.; visualization, E.E.S.; supervision, M.V.Z., D.T., C.M.; project administration, I.V.K., M.V.Z., D.T., C.M.; funding acquisition, I.V.K., M.V.Z.\nFunding: This study was funded by the Ministry of Education and Science of the Republic of Kazakhstan (grant No AP05130947 “Setting the stage for boron neutron capture therapy of cancer in the Republic of Kazakhstan”) and Nazarbayev University “Social Policy Grant” (project title: “Research and development of the new Nano-Optical Sensor based on Polymer Optical Fiber for Near-Field Scanning Optical Microscopy”, PI: Kanat Dukenbayev). The authors also gratefully acknowledge the financial support of the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST «MISiS» (NoK4-2018-036, P02-2017-2-4), implemented by a governmental degree dated 16th of March 2013, No 211. The work was partially supported by Act 211 Government of the Russian Federation, contract No 02.A03.21.0011. This work was partially supported by the Ministry of Education and Science of the Russian Federation (Government task in SUSU 5.5523.2017/8.9).\nConflicts of Interest: The authors declare no conflict of interest."
    } ],
    "references" : [ {
      "title" : "Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications",
      "author" : [ "N.S. Remya", "S. Syama", "A. Sabareeswaran", "P.V. Mohanan" ],
      "venue" : "Int. J. Pharm",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2016
    }, {
      "title" : "PEGylated Iron Oxide Nanoparticles for pH Responsive Drug Delivery Application",
      "author" : [ "S. Chandra Mohanta", "A. Saha", "P. Sujatha Devi" ],
      "venue" : "Mater. Today Proc. 2018,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2018
    }, {
      "title" : "Detailed toxicity evaluation of β-cyclodextrin coated iron oxide nanoparticles for biomedical applications",
      "author" : [ "R. Shelat", "S. Chandra", "A. Khanna" ],
      "venue" : "Int. J. Biol. Macromol",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2018
    }, {
      "title" : "Targeted iron oxide nanoparticles for the enhancement of radiation therapy",
      "author" : [ "A.K. Hauser", "M.I. Mitov", "E.F. Daley", "R.C. McGarry", "K.W. Anderson", "J.Z. Hilt" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2016
    }, {
      "title" : "Ultrasmall iron oxide nanoparticles: Synthesis, surface modification, assembly, and biomedical applications",
      "author" : [ "C. Song", "W. Sun", "Y. Xiao", "X. Shi" ],
      "venue" : "Drug Discov. Today",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2019
    }, {
      "title" : "Kopcansky, P. Chitosan-stabilized iron oxide nanoparticles for magnetic resonance imaging",
      "author" : [ "I. Khmara", "O. Strbak", "V. Zavisova", "M. Koneracka", "M. Kubovcikova", "I. Antal", "V. Kavecansky", "D. Lucanska", "D. Dobrota" ],
      "venue" : "J. Magn. Magn. Mater",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2018
    }, {
      "title" : "Magnetic Particle Imaging-Guided Heating in Vivo Using Gradient Fields for Arbitrary Localization of Magnetic Hyperthermia Therapy",
      "author" : [ "Z.W. Tay", "P. Chandrasekharan", "A. Chiu-Lam", "D.W. Hensley", "R. Dhavalikar", "X.Y. Zhou", "E.Y. Yu", "P.W. Goodwill", "B. Zheng", "C Rinaldi" ],
      "venue" : "ACS Nano 2018,",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2018
    }, {
      "title" : "Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications",
      "author" : [ "S.M. Dadfar", "K. Roemhild", "N.I. Drude", "S. von Stillfried", "R. Knüchel", "F. Kiessling", "T. Lammers" ],
      "venue" : "Adv. Drug Deliv. Rev. 2019,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2019
    }, {
      "title" : "Drug-Carrying Amino Silane Coated Magnetic Nanoparticles as Potential Vehicles for Delivery of Antibiotics",
      "author" : [ "M.H. Mashhadizadeh", "M. Amoli-diva" ],
      "venue" : "J. Nanomed. Nanotechnol",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2012
    }, {
      "title" : "Oxidative esterification of alcohols and aldehydes using supported iron oxide nanoparticle catalysts",
      "author" : [ "F. Rajabi", "R.A.D. Arancon", "R. Luque" ],
      "venue" : "Catal. Commun",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2015
    }, {
      "title" : "Water oxidation electrocatalysis with iron oxide nanoparticles prepared via laser ablation",
      "author" : [ "E. Pizzolato", "S. Scaramuzza", "F. Carraro", "A. Sartori", "S. Agnoli", "V. Amendola", "M. Bonchio", "A. Sartorel" ],
      "venue" : "J. Energy Chem. 2016,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2019
    }, {
      "title" : "Iron oxide nanoparticles synthesis through a benign approach and its catalytic application",
      "author" : [ "H.S. Devi", "T.D. Singh" ],
      "venue" : "Perspect. Sci. 2016,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2016
    }, {
      "title" : "Fluorescence turn-on detection of fenitrothion using gold nanoparticle quenched fluorescein and its separation using superparamagnetic iron oxide nanoparticle",
      "author" : [ "J. Nebu", "J.S. Anjali Devi", "R.S. Aparna", "B. Aswathy", "G.M. Lekha", "G. Sony" ],
      "venue" : "Sens. Actuators B Chem",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2018
    }, {
      "title" : "Separation of excitation and detection coils for in vivo detection of superparamagnetic iron oxide nanoparticles",
      "author" : [ "M.M. van de Loosdrecht", "S. Waanders", "H.J.G. Krooshoop", "B. ten Haken" ],
      "venue" : "J. Magn. Magn. Mater",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2019
    }, {
      "title" : "A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma",
      "author" : [ "J. Koda", "A. Venook", "E. Walser", "S. Goodwin" ],
      "venue" : "Eur. J. Cancer 2002,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2002
    }, {
      "title" : "In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles",
      "author" : [ "H. Arami", "A. Khandhar", "D. Liggitt", "K.M. Krishnan" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2015
    }, {
      "title" : "Accumulation and elimination of iron oxide nanomaterials in zebrafish (Danio rerio) upon chronic aqueous exposure",
      "author" : [ "Y. Zhang", "L. Zhu", "Y. Zhou", "J. Chen" ],
      "venue" : "J. Environ. Sci",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2015
    }, {
      "title" : "Superparamagnetic iron oxide: Pharmacokinetics and toxicity",
      "author" : [ "R. Weissleder", "D. Stark", "B. Engelstad", "B. Bacon", "C. Compton", "D. White", "P. Jacobs", "J. Lewis" ],
      "venue" : "Am. J. Roentgenol",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 1989
    }, {
      "title" : "Characterization of tartaric acid and ascorbic acid coated iron oxide nanoparticles and their biocompatibility studies",
      "author" : [ "F. Ozel", "E. Tokay", "F. Köçkar", "H. Köçkar" ],
      "venue" : "J. Magn. Magn. Mater. 2018",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2018
    }, {
      "title" : "One-Pot Synthesis of Iron Oxide Nanoparticles with Functional Silane Shells: A Versatile General Precursor for Conjugations and Biomedical Applications",
      "author" : [ "V. Yathindranath", "Z. Sun", "M. Worden", "L.J. Donald", "J.A. Thliveris" ],
      "venue" : null,
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2013
    }, {
      "title" : "The Toxicity Assessment of Iron Oxide (Fe3O4) Nanoparticles on Physical and Biochemical Quality of Rainbow Trout Spermatozoon",
      "author" : [ "M. Özgür", "A. Ulu", "S. Balcıoğlu", "İ. Özcan", "S. Köytepe", "B. Ateş" ],
      "venue" : "Toxics 2018,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2018
    }, {
      "title" : "Toxicological assessment of silica-coated iron oxide nanoparticles in human astrocytes",
      "author" : [ "N. Fernández-Bertólez", "C. Costa", "F. Brandão", "G. Kiliç", "J.A. Duarte", "J.P. Teixeira", "E. Pásaro", "V. Valdiglesias", "B. Laffon" ],
      "venue" : "Food Chem. Toxicol",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2018
    }, {
      "title" : "Strategies to optimize the biocompatibility of iron oxide nanoparticles—“SPIONs safe by design",
      "author" : [ "C. Janko", "J. Zaloga", "M. Pöttler", "S. Dürr", "D. Eberbeck", "R. Tietze", "S. Lyer", "C. Alexiou" ],
      "venue" : "J. Magn. Magn. Mater",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2017
    }, {
      "title" : "Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics",
      "author" : [ "R. Alwi", "S. Telenkov", "A. Mandelis", "T. Leshuk", "F. Gu", "S. Oladepo", "K. Michaelian" ],
      "venue" : "Biomed. Opt. Express",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2012
    }, {
      "title" : "Preparation of multifunctional cascade iron oxide nanoparticles for drug",
      "author" : [ "J. Kurczewska", "M. Cegłowski", "G. Schroeder" ],
      "venue" : "delivery. Mater. Chem. Phys",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2018
    }, {
      "title" : "Feasibility for Intramedullary Spinal Glioma",
      "author" : [ "K. Nakai", "A. Matsumura" ],
      "venue" : null,
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2012
    }, {
      "title" : "BNCT for advanced or recurrent head and neck cancer",
      "author" : [ "T. Aihara", "N. Morita", "N. Kamitani", "H. Kumada", "K. Ono", "J. Hiratsuka", "T. Harada" ],
      "venue" : "Appl. Radiat. Isot",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2014
    }, {
      "title" : "Boron Neutron Capture Therapy for Breast Cancer",
      "author" : [ "Z. Akan" ],
      "venue" : "Int. J. Women’s Heal. Reprod. Sci. 2015,",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2015
    }, {
      "title" : "Swedish Brain Tumour Study Group Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)",
      "author" : [ "R. Henriksson", "J. Capala", "A. Michanek", "S.-Å. Lindahl", "L.G. Salford", "L. Franzén", "E. Blomquist", "J.-E. Westlin", "A.T. Bergenheim" ],
      "venue" : "Radiother. Oncol",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2008
    }, {
      "title" : "Principles and Roots of Neutron Capture Therapy",
      "author" : [ "W.A.G. Sauerwein" ],
      "venue" : "Nanomaterials 2019,",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2012
    }, {
      "title" : "Synthesis of bis(dialkylaminomethyl)-o- and m-carboranes and study of these compounds as potential preparations for boron neutron capture therapy",
      "author" : [ "L.I. Zakharkin", "V.A. Ol’shevskaya", "R.A. Spryshkova", "E.Y. Grigor’eva", "V.I. Ryabkova", "G.I. Borisov" ],
      "venue" : "Pharm. Chem. J",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2000
    }, {
      "title" : "Strategies to Improve the Efficacy of Neutron Capture Therapy of Brain Tumors by Optimizing Delivery of Boron Compounds",
      "author" : [ "R.F. Barth", "W. Yang", "A.H. Soloway" ],
      "venue" : "In Frontiers in Neutron Capture Therapy; Springer US:",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2001
    }, {
      "title" : "Carborane confined nanoparticles for boron neutron capture therapy: Improved stability, blood circulation time and tumor accumulation",
      "author" : [ "S. Sumitani", "M. Oishi", "Y. Nagasaki" ],
      "venue" : "React. Funct. Polym",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2011
    }, {
      "title" : "Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer",
      "author" : [ "R.H. Pak", "F.J. Primus", "K.J. Rickard-Dickson", "L.L. Ng", "R.R. Kane", "M.F. Hawthorne" ],
      "venue" : "Proc. Natl. Acad. Sci. USA",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 1995
    }, {
      "title" : "Transferrin-Loaded nido-Carborane Liposomes: Tumor-Targeting Boron Delivery System for Neutron Capture Therapy",
      "author" : [ "Y. Miyajima", "H. Nakamura", "Y. Kuwata", "J.-D. Lee", "S. Masunaga", "K. Kazuo Maruyama Ono" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2006
    }, {
      "title" : "Carborane Derivatives Loaded into Liposomes as Efficient Delivery Systems for Boron Neutron Capture Therapy",
      "author" : [ "S. Altieri", "M. Balzi", "S. Bortolussi", "P. Bruschi", "L. Ciani", "A.M. Clerici", "P. Faraoni", "C. Ferrari", "M.A. Gadan", "L Panza" ],
      "venue" : "J. Med. Chem",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2009
    }, {
      "title" : "Substituted Carborane-Appended Water-Soluble Single-Wall Carbon Nanotubes: New Approach to Boron Neutron Capture Therapy Drug Delivery",
      "author" : [ "Z. Yinghuai", "A.T. Peng", "K. Carpenter", "J.A. Maguire", "N.S. Masao Takagaki Hosmane" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2005
    }, {
      "title" : "Preparation and characterization of Au nanoparticles capped with mercaptocarboranyl clusters",
      "author" : [ "A.M. Cioran", "F. Teixidor", "Ž. Krpetić", "M. Brust", "C. Viñas" ],
      "venue" : "Dalton Trans",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2014
    }, {
      "title" : "Boron Drug Delivery via Encapsulated Magnetic Nanocomposites: A New Approach for BNCT in Cancer Treatment",
      "author" : [ "Y. Zhu", "Y. Lin", "Y.Z. Zhu", "J. Lu", "J.A. Maguire", "N.S. Hosmane" ],
      "venue" : "J. Nanomater",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2010
    }, {
      "title" : "Nanotechnology-driven chemistry of boron materials",
      "author" : [ "A. Chakrabarti", "N.S. Hosmane" ],
      "venue" : "Pure Appl. Chem",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2012
    }, {
      "title" : "Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: Where are we now",
      "author" : [ "M. Bietenbeck", "A. Florian", "C. Faber", "U. Sechtem", "A. Yilmaz" ],
      "venue" : "Int. J. Nanomed. 2016,",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2016
    }, {
      "title" : "Immobilization of carborane derivatives on Ni/Fe nanotubes for BNCT",
      "author" : [ "I.V. Korolkov", "A.L. Kozlovskiy", "Y.G. Gorin", "A.V. Kazantsev", "D.I. Shlimas", "M.V. Zdorovets", "N.K. Ualieva", "V.S. Rusakov" ],
      "venue" : "J. Nanopart. Res",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2018
    }, {
      "title" : "Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications; Wiley-Blackwell",
      "author" : [ "R.I. Freshney" ],
      "venue" : null,
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2010
    }, {
      "title" : "Differentiation of primary and secondary fibroblasts in cell culture systems",
      "author" : [ "K. Bayreuther", "P.I. Francz", "J. Gogol", "C. Hapke", "M. Maier", "H.G. Meinrath" ],
      "venue" : "Mutat. Res",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 1991
    }, {
      "title" : "Synthesis of Fe3O4nanoparticles for biomedical applications",
      "author" : [ "K. Onar", "M.E. Yakinci" ],
      "venue" : "J. Phys. Conf. Ser",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2016
    }, {
      "title" : "Size-Controlled Synthesis of Magnetite Nanoparticles in the Presence of Polyelectrolytes",
      "author" : [ "S. Si", "A. Kotal", "T.K. Mandal", "S. Giri", "A. Hiroyuki Nakamura", "T. Kohara" ],
      "venue" : "Chem. Mater",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2004
    }, {
      "title" : "Hydrothermal Synthesis of Monodisperse Magnetite Nanoparticles",
      "author" : [ "T.J. Daou", "G. Pourroy", "S. Bégin-Colin", "J.M. Grenèche", "C. Ulhaq-Bouillet", "P. Legaré", "P. Bernhardt", "C. Leuvrey", "G. Rogez" ],
      "venue" : "Chem. Mater",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2006
    }, {
      "title" : "Induction heating studies of Fe3O4 magnetic nanoparticles capped with oleic acid and polyethylene glycol for hyperthermia",
      "author" : [ "R. Ghosh", "L. Pradhan", "Y.P. Devi", "S.S. Meena", "R. Tewari", "A. Kumar", "S. Sharma", "N.S. Gajbhiye", "R.K. Vatsa", "B.N Pandey" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2011
    }, {
      "title" : "Synthesis and Mössbauer study of 57Fe-based nanoparticles biodegradation in living cells",
      "author" : [ "A. Yurenya", "A. Nikitin", "A. Garanina", "R. Gabbasov", "M. Polikarpov", "V. Cherepanov", "M. Chuev", "A. Majouga", "V. Panchenko" ],
      "venue" : "J. Magn. Magn. Mater",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2019
    }, {
      "title" : "Mössbauer spectroscopy and magnetic properties of hematite/magnetite nanocomposites",
      "author" : [ "I.S. Lyubutin", "C.R. Lin", "Y.V. Korzhetskiy", "T.V. Dmitrieva", "R.K. Chiang" ],
      "venue" : "J. Appl. Phys",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2009
    }, {
      "title" : "Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer",
      "author" : [ "G. Kandasamy", "D. Maity" ],
      "venue" : "nanotheranostics. Int. J. Pharm",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2015
    }, {
      "title" : "Synthesis, Surface Modification and Characterisation of Biocompatible Magnetic Iron Oxide Nanoparticles for Biomedical Applications",
      "author" : [ "M. Mahdavi", "M. Ahmad", "M. Haron", "F. Namvar", "B. Nadi", "M. Rahman", "J. Amin" ],
      "venue" : "Molecules",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2013
    }, {
      "title" : "Aminopropyltriethoxysilane-mediated surface functionalization of hydroxyapatite nanoparticles: Synthesis, characterization, and in vitro toxicity assay",
      "author" : [ "X. Shi", "S. Wang", "M. Wen", "R. Shen", "X. Guo", "J. Cao", "X. Wang" ],
      "venue" : "Int. J. Nanomed",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2011
    }, {
      "title" : "Mössbauer Study of Electron Hopping in the Octahedral Sites of Fe3O4",
      "author" : [ "G.A. Sawatzky", "J.M.D. Coey", "A.H. Morrish" ],
      "venue" : "J. Appl. Phys",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 1969
    }, {
      "title" : "Magnetic, X-ray and Mössbauer studies on magnetite/maghemite core–shell nanostructures fabricated through an aqueous route",
      "author" : [ "S.J. Iyengar", "M. Joy", "C.K. Ghosh", "S. Dey", "R.K. Kotnala", "S. Ghosh" ],
      "venue" : "RSC Adv",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2014
    }, {
      "title" : "Synthesis and characterization of PVP-functionalized superparamagnetic Fe3O4 nanoparticles as an MRI contrast agent",
      "author" : [ "N. Arsalani", "H. Fattahi", "M. Nazarpoor" ],
      "venue" : "Express Polym. Lett. 2010,",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2010
    }, {
      "title" : "Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agent",
      "author" : [ "A.R. Chowdhuri", "D. Bhattacharya", "S.K. Sahu" ],
      "venue" : "Dalt. Trans",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2016
    }, {
      "title" : "Magnetic nanoparticles for drug delivery",
      "author" : [ "J. Dobson" ],
      "venue" : "Drug Dev. Res",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2006
    }, {
      "title" : "The use of multiple pseudo-physiological solutions to simulate the degradation behavior of pure iron as a metallic resorbable implant: A surface-characterization study",
      "author" : [ "R. Tolouei", "J. Harrison", "C. Paternoster", "S. Turgeon", "P. Chevallier", "D. Mantovani" ],
      "venue" : "Phys. Chem. Chem. Phys. 2016,",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 1963
    }, {
      "title" : "Studies of the Colloidal Properties of Superparamagnetic Iron Oxide Nanoparticles Functionalized with Platinum Complexes in Aqueous and PBS Buffer Media",
      "author" : [ "G. da Silva", "M. Marciello", "M. del Puerto Morales", "C. Serna", "M. Vargas", "C. Ronconi", "R. Costo" ],
      "venue" : "J. Braz. Chem. Soc",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2016
    }, {
      "title" : "New insights into the degradation mechanism of metal-organic frameworks drug",
      "author" : [ "X. Li", "L. Lachmanski", "S. Safi", "S. Sene", "C. Serre", "J.M. Grenèche", "J. Zhang", "R. Gref" ],
      "venue" : "carriers. Sci. Rep. 2017,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2017
    }, {
      "title" : "Investigation of the influence of irradiation with Fe+7 ions on structural properties of AlN ceramics",
      "author" : [ "A. Kozlovskiy", "K. Dukenbayev", "I. Ivanov", "S. Kozin", "V. Aleksandrenko", "A. Kurakhmedov", "E. Sambaev", "I. Kenzhina", "D. Tosi", "V Loginov" ],
      "venue" : "Mater. Res. Express 2018,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2018
    }, {
      "title" : "The Effect of Degree of Crystallinity on the Infrared Spectrum of Hematite",
      "author" : [ "E. Mendelovici", "S. Yariv" ],
      "venue" : "Appl. Spectrosc. 1979,",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 1979
    }, {
      "title" : "Radical induced degradation of acetaminophen with Fe3O4 magnetic nanoparticles as heterogeneous activator of peroxymonosulfate",
      "author" : [ "C. Tan", "N. Gao", "Y. Deng", "J. Deng", "S. Zhou", "J. Li", "X. Xin" ],
      "venue" : "J. Hazard. Mater",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2014
    }, {
      "title" : "CoFe2O4 magnetic nanoparticles as a highly active heterogeneous catalyst of oxone for the degradation of diclofenac in water",
      "author" : [ "J. Deng", "Y. Shao", "N. Gao", "C. Tan", "S. Zhou", "X. Hu" ],
      "venue" : "J. Hazard. Mater",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2013
    }, {
      "title" : "Semiconductor clusters in the sol-gel process: Quantized aggregation, gelation, and crystal growth in concentrated zinc oxide colloids",
      "author" : [ "L. Spanhel", "M.A. Anderson" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 1991
    }, {
      "title" : "Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging",
      "author" : [ "F. Ye", "Å. Barrefelt", "H. Asem", "M. Abedi-Valugerdi", "I. El-Serafi", "M. Saghafian", "K. Abu-Salah", "S. Alrokayan", "M. Muhammed", "M. Hassan" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2014
    }, {
      "title" : "Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles",
      "author" : [ "M. Chorny", "E. Hood", "R.J. Levy", "V.R. Muzykantov" ],
      "venue" : "J. Control. Release",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2010
    }, {
      "title" : "Biodegradation of Magnetic Nanoparticles in Mouse Liver From Combined Analysis of Mössbauer and Magnetization Data",
      "author" : [ "R. Gabbasov", "V. Cherepanov", "M. Chuev", "M. Polikarpov", "M. Nikitin", "S. Deyev", "V. Panchenko" ],
      "venue" : "IEEE Trans. Magn",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2013
    }, {
      "title" : "Magnetic Nanoparticle Degradation in vivo Studied by Mössbauer Spectroscopy",
      "author" : [ "M. Nikitin", "R. Gabbasov", "V. Cherepanov", "M. Chuev", "M. Polikarpov", "V. Panchenko", "S. Deyev" ],
      "venue" : "AIP Conf. Proc",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2010
    }, {
      "title" : "The Degradation of Poly (ethy1ene terephthalate)",
      "author" : [ "L.H. Buxbaum" ],
      "venue" : "Angew. Chem. Internat. Ed",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 1968
    }, {
      "title" : "Attachment of 3-(Aminopropyl) triethoxysilane on Silicon Oxide Surfaces: Dependence on Solution Temperature",
      "author" : [ "R.M. Pasternack", "S.R. Amy", "Y.J. Chabal" ],
      "venue" : "Langmuir 2008,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2008
    }, {
      "title" : "Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats",
      "author" : [ "T.K. Jain", "M.K. Reddy", "M.A. Morales", "D.L. Leslie-Pelecky", "V. Labhasetwar" ],
      "venue" : "Mol. Pharm. 2008,",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2008
    }, {
      "title" : "Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications",
      "author" : [ "S. Laurent", "D. Forge", "M. Port", "A. Roch", "C. Robic", "L. Vander Elst", "R.N. Muller" ],
      "venue" : "Chem. Rev",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2010
    }, {
      "title" : "Interaction of Poly(amidoamine) Dendrimers with Supported Lipid Bilayers and Cells: Hole Formation and the Relation to Transport",
      "author" : [ "S. Hong", "A.U. Bielinska", "A. Mecke", "B. Keszler", "J.L. Beals", "X. Shi", "L. Balogh", "B.G. Orr", "J.R. Baker", "M.M. Banaszak Holl" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2004
    } ],
    "referenceMentions" : [ {
      "referenceID" : 12,
      "context" : "Magnetic iron oxide nanoparticles (NPs), such as magnetite (Fe3O4) and maghemite (γ-Fe2O3), have been found and applied in a wide range of biomedical applications [1–9], including magnetic resonance imaging, magnetic hyperthermia, cancer therapy, and drug delivery; they also find applications in catalysis [10–12] and in magnetic separation [13,14].",
      "startOffset" : 342,
      "endOffset" : 349
    }, {
      "referenceID" : 13,
      "context" : "Magnetic iron oxide nanoparticles (NPs), such as magnetite (Fe3O4) and maghemite (γ-Fe2O3), have been found and applied in a wide range of biomedical applications [1–9], including magnetic resonance imaging, magnetic hyperthermia, cancer therapy, and drug delivery; they also find applications in catalysis [10–12] and in magnetic separation [13,14].",
      "startOffset" : 342,
      "endOffset" : 349
    }, {
      "referenceID" : 14,
      "context" : "Among other metal nanoparticles, iron oxide nanoparticles have been more extensively studied in clinical practice [15].",
      "startOffset" : 114,
      "endOffset" : 118
    }, {
      "referenceID" : 7,
      "context" : "A wide range of Fe3O4 NPs’ applications are derived from unique properties, such as the superparamagnetism, high surface area, and nanometer-level size [8].",
      "startOffset" : 152,
      "endOffset" : 155
    }, {
      "referenceID" : 15,
      "context" : "[16] showed that iron oxide NPs are safe and non-toxic with a median lethal dose of 300–600 mgFe/kg.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 16,
      "context" : "[17] reported that the accumulation and elimination of iron oxide NPs were found on a sample of zebrafish, and as a result, magnetic nanoparticles were eliminated from 86% to 100% by 24 days.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 17,
      "context" : "[18] studied the toxic effect on rats and beagle dogs, revealing that no toxicity was detected in animals that received 3000 mmol Fe/kg overall.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 25,
      "context" : "BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31].",
      "startOffset" : 59,
      "endOffset" : 66
    }, {
      "referenceID" : 26,
      "context" : "BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31].",
      "startOffset" : 59,
      "endOffset" : 66
    }, {
      "referenceID" : 27,
      "context" : "BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31].",
      "startOffset" : 171,
      "endOffset" : 175
    }, {
      "referenceID" : 28,
      "context" : "BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31].",
      "startOffset" : 190,
      "endOffset" : 194
    }, {
      "referenceID" : 29,
      "context" : "BNCT was primarily used for head and neck cancer treatment [27,28], but improvements of the method turned it into a promising therapy for soft tissues, like breast cancer [29], glioblastoma [30], melanomas of the skin, and liver metastases [31].",
      "startOffset" : 240,
      "endOffset" : 244
    }, {
      "referenceID" : 30,
      "context" : "However, BNCT has limitations, which are the high concentration of thermal neutrons in the order of 10 n/cm2 and high concentration of boron-10 in the tumor (20–35 μg per 1 g of tissue) [32,33].",
      "startOffset" : 186,
      "endOffset" : 193
    }, {
      "referenceID" : 31,
      "context" : "However, BNCT has limitations, which are the high concentration of thermal neutrons in the order of 10 n/cm2 and high concentration of boron-10 in the tumor (20–35 μg per 1 g of tissue) [32,33].",
      "startOffset" : 186,
      "endOffset" : 193
    }, {
      "referenceID" : 32,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 140,
      "endOffset" : 144
    }, {
      "referenceID" : 33,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 168,
      "endOffset" : 172
    }, {
      "referenceID" : 34,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 184,
      "endOffset" : 191
    }, {
      "referenceID" : 35,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 184,
      "endOffset" : 191
    }, {
      "referenceID" : 36,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 210,
      "endOffset" : 214
    }, {
      "referenceID" : 37,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 235,
      "endOffset" : 239
    }, {
      "referenceID" : 38,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 269,
      "endOffset" : 276
    }, {
      "referenceID" : 39,
      "context" : "These drawbacks can be improved by the immobilization of different boron-rich compounds, such as carboranes, into carriers such as micelles [34], monoclonic antibodies [35], liposomes [36,37], carbon nanotubes [38], gold nanoparticles [39], and magnetic nanostructures [40,41].",
      "startOffset" : 269,
      "endOffset" : 276
    }, {
      "referenceID" : 40,
      "context" : "Among them, magnetic iron oxide NPs are preferable due to the potential possibility of drug targeting into each specific site of the disease [42].",
      "startOffset" : 141,
      "endOffset" : 145
    }, {
      "referenceID" : 38,
      "context" : "[40] studied the effective method of carborane (10 atoms per molecule) immobilization on Fe3O4 NPs by catalytic azide-alkyne cycloaddition reactions.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 41,
      "context" : "1 M  solution  of carborane borate, synthesized as in [43]    in ethanol, and the reaction mixture was ultrasonicated for 30 min and was kept in a shaker for 24 h.",
      "startOffset" : 54,
      "endOffset" : 58
    }, {
      "referenceID" : 41,
      "context" : "1 M solution of carborane rate, synth sized as in [43] in ethanol, and the reaction mixture was ultrasonica ed for 30 min and was kept in a shaker for 24 h.",
      "startOffset" : 50,
      "endOffset" : 54
    }, {
      "referenceID" : 42,
      "context" : "25% trypsin solution at 37 ◦C for 30 min [44].",
      "startOffset" : 41,
      "endOffset" : 45
    }, {
      "referenceID" : 43,
      "context" : "The number of cells of different morphotypes was counted in accordance with the classification of Bayreuter [45].",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 44,
      "context" : "Fe3O4 NPs were synthesized using a mixture of iron (II) and (III) chloride with the addition of ammonium hydroxide [46].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 44,
      "context" : "Fe3O4 NPs were synthesized using a mixture of iron (II) and (III) chloride with the addition of ammonium hyd oxide [46].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 45,
      "context" : "1 kOe, respectively, which is in good agreement with the literature data on the magnitudes of the hyperfine fields for magnetite nanostructures [47,48].",
      "startOffset" : 144,
      "endOffset" : 151
    }, {
      "referenceID" : 46,
      "context" : "1 kOe, respectively, which is in good agreement with the literature data on the magnitudes of the hyperfine fields for magnetite nanostructures [47,48].",
      "startOffset" : 144,
      "endOffset" : 151
    }, {
      "referenceID" : 50,
      "context" : "Increased fragments of loops (in the range of B = ±1000 Oe) demonstrate the magnetic characteristics: Coercivity is about 10 Oe, saturation magnetization is 68 emu/g, which is typical for Fe3O4 magnetic NPs [52].",
      "startOffset" : 207,
      "endOffset" : 211
    }, {
      "referenceID" : 50,
      "context" : "The increased fragments of loops (in the range of B = ±1000 Oe) demonstrate the magnetic characteristics: Coercivity is about 10 Oe, saturation magnetization is 68 emu/g, which is typical for Fe3O4 magnetic NPs [52,53].",
      "startOffset" : 211,
      "endOffset" : 218
    }, {
      "referenceID" : 51,
      "context" : "The increased fragments of loops (in the range of B = ±1000 Oe) demonstrate the magnetic characteristics: Coercivity is about 10 Oe, saturation magnetization is 68 emu/g, which is typical for Fe3O4 magnetic NPs [52,53].",
      "startOffset" : 211,
      "endOffset" : 218
    }, {
      "referenceID" : 52,
      "context" : "30458 Å for the modified samples indicates the interaction of these compounds (APTMS) with the crystalline structure of NPs by replacing iron or oxygen atoms in the lattice sites or introducing them into interstitial sites [54].",
      "startOffset" : 223,
      "endOffset" : 227
    }, {
      "referenceID" : 52,
      "context" : "30458 Å for the modified samples indicates the interaction of these compounds (APTMS) with the crystalline structure of NPs by replacing iron or oxygen atoms in the lattice sites or introducing them into interstitial sites [54].",
      "startOffset" : 223,
      "endOffset" : 227
    }, {
      "referenceID" : 47,
      "context" : "7 kOe is due to the modification of the NPs’ surface, the change in the structural bonds, and the introduction of –Si, –O, and –NH3 into the interstice of the crystal lattice, thus leading to its change [49,55,56].",
      "startOffset" : 203,
      "endOffset" : 213
    }, {
      "referenceID" : 53,
      "context" : "7 kOe is due to the modification of the NPs’ surface, the change in the structural bonds, and the introduction of –Si, –O, and –NH3 into the interstice of the crystal lattice, thus leading to its change [49,55,56].",
      "startOffset" : 203,
      "endOffset" : 213
    }, {
      "referenceID" : 54,
      "context" : "7 kOe is due to the modification of the NPs’ surface, the change in the structural bonds, and the introduction of –Si, –O, and –NH3 into the interstice of the crystal lattice, thus leading to its change [49,55,56].",
      "startOffset" : 203,
      "endOffset" : 213
    }, {
      "referenceID" : 55,
      "context" : "Increased fragments (inserts to Figure 3g) of loops (in the range of B = ±1000 Oe) demonstrate a slight decrease in the magnetic characteristics in comparison with the initial Fe3O4 NPs, caused by changing the present nonmagnetic faze on the magnetic NPs’ surface: Coercivity is about 6 Oe, saturation magnetization is 62 emu/g, and this is close to the magnetic parameters of Fe3O4 NPs, as indicated in [57].",
      "startOffset" : 404,
      "endOffset" : 408
    }, {
      "referenceID" : 53,
      "context" : "The obtained results are in good agreement with previous work on the functionalization of the surface of oxide nanoparticles and their potential use in biomedicine and targeted drug delivery [55,58,59].",
      "startOffset" : 191,
      "endOffset" : 201
    }, {
      "referenceID" : 56,
      "context" : "The obtained results are in good agreement with previous work on the functionalization of the surface of oxide nanoparticles and their potential use in biomedicine and targeted drug delivery [55,58,59].",
      "startOffset" : 191,
      "endOffset" : 201
    }, {
      "referenceID" : 57,
      "context" : "The obtained results are in good agreement with previous work on the functionalization of the surface of oxide nanoparticles and their potential use in biomedicine and targeted drug delivery [55,58,59].",
      "startOffset" : 191,
      "endOffset" : 201
    }, {
      "referenceID" : 61,
      "context" : "By approximating the lines of the diffractogram with the necessary number of symmetric pseudo‐Voigt functions, the width of the recorded lines at half of their height (FWHM, full‐width half maximum) was measured, which allowed us to characterize the perfection of the crystal structure and estimate the degree of crystallinity [63,64]: PV x, x , η, b , b , A A 1 η G x, x , b η L x, x , b ,",
      "startOffset" : 327,
      "endOffset" : 334
    }, {
      "referenceID" : 62,
      "context" : "By approximating the lines of the diffractogram with the necessary number of symmetric pseudo‐Voigt functions, the width of the recorded lines at half of their height (FWHM, full‐width half maximum) was measured, which allowed us to characterize the perfection of the crystal structure and estimate the degree of crystallinity [63,64]: PV x, x , η, b , b , A A 1 η G x, x , b η L x, x , b ,",
      "startOffset" : 327,
      "endOffset" : 334
    }, {
      "referenceID" : 61,
      "context" : "By approximating the lines of the diffractogram with the necessary number of symmetric pseudo-Voigt functions, the width of the recorded lines at half of their height (FWHM, full-width half maximum) was measured, which allowed us to characterize the perfection of the crystal structure and estimate the degree of crystallinity [63,64]:",
      "startOffset" : 327,
      "endOffset" : 334
    }, {
      "referenceID" : 62,
      "context" : "By approximating the lines of the diffractogram with the necessary number of symmetric pseudo-Voigt functions, the width of the recorded lines at half of their height (FWHM, full-width half maximum) was measured, which allowed us to characterize the perfection of the crystal structure and estimate the degree of crystallinity [63,64]:",
      "startOffset" : 327,
      "endOffset" : 334
    }, {
      "referenceID" : 63,
      "context" : "According to the data, the largest increase in the lattice parameter is also observed for unmodified Fe3O4 NPs, which is caused by the processes of the introduction of oxygen ions into the internode of the crystal lattice and its subsequent swelling [65,66].",
      "startOffset" : 250,
      "endOffset" : 257
    }, {
      "referenceID" : 64,
      "context" : "According to the data, the largest increase in the lattice parameter is also observed for unmodified Fe3O4 NPs, which is caused by the processes of the introduction of oxygen ions into the internode of the crystal lattice and its subsequent swelling [65,66].",
      "startOffset" : 250,
      "endOffset" : 257
    }, {
      "referenceID" : 65,
      "context" : "The crystallite size was estimated using the Debye-Scherer method [67].",
      "startOffset" : 66,
      "endOffset" : 70
    }, {
      "referenceID" : 66,
      "context" : "Degradation for 1 day led to a sharp increase in the average crystallite size of initial Fe3O4 NPs, which may be due to the incorporation of oxygen into the nanoparticle structure, in which changing the main crystallographic characteristics leads to a decrease in the degree of perfection of the crystal structure due to the formation of amorphous inclusions [68,69].",
      "startOffset" : 359,
      "endOffset" : 366
    }, {
      "referenceID" : 67,
      "context" : "Degradation for 1 day led to a sharp increase in the average crystallite size of initial Fe3O4 NPs, which may be due to the incorporation of oxygen into the nanoparticle structure, in which changing the main crystallographic characteristics leads to a decrease in the degree of perfection of the crystal structure due to the formation of amorphous inclusions [68,69].",
      "startOffset" : 359,
      "endOffset" : 366
    }, {
      "referenceID" : 68,
      "context" : "The results of a change in the magnitude of the hyperfine magnetic field, determined by Mössbauer spectroscopy, depending on the time of degradation, show that an increase in the degradation time leads to a change in the structural characteristics and the formation of amorphous inclusions in the structure, which in turn leads to a decrease in the magnitude of the hyperfine magnetic field [70,71].",
      "startOffset" : 391,
      "endOffset" : 398
    }, {
      "referenceID" : 69,
      "context" : "The results of a change in the magnitude of the hyperfine magnetic field, determined by Mössbauer spectroscopy, depending on the time of degradation, show that an increase in the degradation time leads to a change in the structural characteristics and the formation of amorphous inclusions in the structure, which in turn leads to a decrease in the magnitude of the hyperfine magnetic field [70,71].",
      "startOffset" : 391,
      "endOffset" : 398
    }, {
      "referenceID" : 70,
      "context" : "This is due to the formation of cationic vacancies and impurity inclusions in the structure, as well as the disordering of the magnetic texture [72].",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 59,
      "context" : "At the same time, the products of degradation, such as FeOOH or Fe3(PO4)2, as they were previously reported in [61,62] were not detected.",
      "startOffset" : 111,
      "endOffset" : 118
    }, {
      "referenceID" : 60,
      "context" : "At the same time, the products of degradation, such as FeOOH or Fe3(PO4)2, as they were previously reported in [61,62] were not detected.",
      "startOffset" : 111,
      "endOffset" : 118
    }, {
      "referenceID" : 72,
      "context" : "1  kOe  for  samples with  attached carborane borate is due to the modification of the NPs’ surface [74,75].",
      "startOffset" : 100,
      "endOffset" : 107
    }, {
      "referenceID" : 73,
      "context" : "1  kOe  for  samples with  attached carborane borate is due to the modification of the NPs’ surface [74,75].",
      "startOffset" : 100,
      "endOffset" : 107
    }, {
      "referenceID" : 41,
      "context" : "The presented results are in good correlation with previously published work [43,73].",
      "startOffset" : 77,
      "endOffset" : 84
    }, {
      "referenceID" : 71,
      "context" : "The presented results are in good correlation with previously published work [43,73].",
      "startOffset" : 77,
      "endOffset" : 84
    }, {
      "referenceID" : 72,
      "context" : "1 kOe for samples with attached carborane borate is due to the modification of the NPs’ surface [74,75].",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 73,
      "context" : "1 kOe for samples with attached carborane borate is due to the modification of the NPs’ surface [74,75].",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 7,
      "context" : "Fe3O4 NPs’ toxicity depends on a variety of factors, including the dose, exposure time, colloidal and chemical properties of the surface, the NPs’ hydrodynamic diameter, and NPs’ protein interactions [8].",
      "startOffset" : 200,
      "endOffset" : 203
    }, {
      "referenceID" : 52,
      "context" : "The  increased  cytotoxicity of NPs  coated with APTMS  can be explained by  the  fact  that  the surface of Fe3O4‐Aminated NPs  contains positively  charged NH2‐groups  that  can electrostatically interact  with  negatively  charged  cell  membranes  [54,76].",
      "startOffset" : 252,
      "endOffset" : 259
    }, {
      "referenceID" : 74,
      "context" : "The  increased  cytotoxicity of NPs  coated with APTMS  can be explained by  the  fact  that  the surface of Fe3O4‐Aminated NPs  contains positively  charged NH2‐groups  that  can electrostatically interact  with  negatively  charged  cell  membranes  [54,76].",
      "startOffset" : 252,
      "endOffset" : 259
    }, {
      "referenceID" : 52,
      "context" : "The increased cytotoxicity of NPs coated with APTMS can be explained by the fact that the surface of Fe3O4-Aminated NPs contains positively charged NH2-groups that can electrostatically interact with negatively charged cell membranes [54,76].",
      "startOffset" : 234,
      "endOffset" : 241
    }, {
      "referenceID" : 74,
      "context" : "The increased cytotoxicity of NPs coated with APTMS can be explained by the fact that the surface of Fe3O4-Aminated NPs contains positively charged NH2-groups that can electrostatically interact with negatively charged cell membranes [54,76].",
      "startOffset" : 234,
      "endOffset" : 241
    } ],
    "year" : 2019,
    "abstractText" : "Magnetic Fe3O4 nanoparticles (NPs) and their surface modification with therapeutic substances are of great interest, especially drug delivery for cancer therapy, including boron-neutron capture therapy (BNCT). In this paper, we present the results of boron-rich compound (carborane borate) attachment to previously aminated by (3-aminopropyl)-trimethoxysilane (APTMS) iron oxide NPs. Fourier transform infrared spectroscopy with Attenuated total reflectance accessory (ATR-FTIR) and energy-dispersive X-ray analysis confirmed the change of the element content of NPs after modification and formation of new bonds between Fe3O4 NPs and the attached molecules. Transmission (TEM) and scanning electron microscopy (SEM) showed Fe3O4 NPs’ average size of 18.9 nm. Phase parameters were studied by powder X-ray diffraction (XRD), and the magnetic behavior of Fe3O4 NPs was elucidated by Mössbauer spectroscopy. The colloidal and chemical stability of NPs was studied using simulated body fluid (phosphate buffer—PBS). Modified NPs have shown excellent stability in PBS (pH = 7.4), characterized by XRD, Mössbauer spectroscopy, and dynamic light scattering (DLS). Biocompatibility was evaluated in-vitro using cultured mouse embryonic fibroblasts (MEFs). The results show us an increasing of IC50 from 0.110 mg/mL for Fe3O4 NPs to 0.405 mg/mL for Fe3O4-Carborane NPs. The obtained data confirm the biocompatibility and stability of synthesized NPs and the potential to use them in BNCT.",
    "creator" : "LaTeX with hyperref package"
  }
}